Breaking News

EUROAPI Reports Progressive Restart of Prostaglandin Production

Majority of production at the Budapest site expected to be back online by mid-April 2023.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

EUROAPI progressively restarted prostaglandin production at its Budapest site on January 19, 2023. As first reported in its press release of December 7, 2022, EUROAPI identified certain Good Manufacturing Practices deficiencies related to production documentation during an internal assessment and decided to temporarily suspend prostaglandin activities at its Budapest site. The company said it has built and implemented a remediation plan, allowing to progressively restart prostaglandin prod...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters